Risk of thromboembolic phenomena in patients with inflammatory bowel disease

被引:7
作者
Suarez Ferrer, Cristina [1 ]
Vera Mendoza, Maria Isabel [1 ]
Amo San Roman, Leticia [1 ]
Gonzalez Lama, Yago [1 ]
Calvo Moya, Marta [1 ]
Garcia Casas, Mercedes [1 ]
Abreu Garcia, Luis [1 ]
机构
[1] Hosp Univ Puerta de Hierro, Serv Gastroenterol & Hepatol, Madrid, Spain
来源
GASTROENTEROLOGIA Y HEPATOLOGIA | 2012年 / 35卷 / 09期
关键词
Thromboembolic phenomena; Inflammatory bowel disease; Risk of thrombosis; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM;
D O I
10.1016/j.gastrohep.2012.07.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Inflammatory bowel disease (IBD) is an independent risk factor for thromboembolic phenomena (TEP). We evaluated the prevalence and the possible risk factors associated with developing TEP in patients with IBD in our center. Material and methods: Data were retrospectively collected from January 1995 to December 2011 from 23 patients. A total of 61% were diagnosed with Crohn's disease (CD) and 39% with ulcerative colitis (UC) according to routine criteria. Results: When the Montreal classification was used, 58% of the patients with CD had an inflammatory pattern (B1), 25% a stenosing pattern (B2) and 17% a fistulizing pattern (B3). Half the patients had ileocolic involvement (L3), one-third had colonic involvement (L2) and the remainder had Heal involvement (L1). Among patients with UC according to the Montreal classification, 78% had extensive colitis (E3), 11% had left colonic involvement (E2) and 11% had proctocolitis (El). During the event, almost half the patients with UC had severe inflammatory activity (S3; 44%), 33% had mild-moderate activity (51: 22%, S2: 11%) and only 22% were in remission (SO). Overall, at the time of the TEP, 48% of the patients had mild-moderate activity and 22% had severe activity. Likewise, 44% were hospitalized at the time of the event. In UC, an increase in the prevalence of TEP was found in admitted patients (66%). None of the patients had a family history of TER two patients (9%) had associated thrombophilia and 26% were active smokers. There were no TEP during pregnancy. Only one patient was taking contraceptive pills when the event occurred. The most frequent forms of TEP were deep vein thrombosis of the legs (55%) followed by pulmonary thromboembolism (25%). Conclusions: TEP are relatively frequent in patients with IBD, with a strong impact on morbidity and mortality. In our series, risk factors for these events were more extensive involvement (any of the groups) and severe inflammatory activity. No significant association between classical risk factors such as the use of contraceptives, pregnancy, coagulation disorders or smoking and the risk of TEP were found. (C) 2012 Elsevier Espana, S.L. and AEEH y AEG. All rights reserved.
引用
收藏
页码:634 / 639
页数:6
相关论文
共 50 条
  • [21] Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort
    Alatri, Adriano
    Schoepfer, Alain
    Fournier, Nicolas
    Engelberger, Rolf Peter
    Safroneeva, Ekaterina
    Vavricka, Stephan
    Biedermann, Luc
    Calanca, Luca
    Mazzolai, Lucia
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (10) : 1200 - 1205
  • [22] Hypoalbuminemia as a risk factor for thromboembolic events in inflammatory bowel disease inpatients
    Imbrizi, Marcello Rabello
    Magro, Daniela Oliveira
    Lopes Secundo, Tirzah de Mendonca
    Cunha-Silva, Marlone
    Kotze, Paulo Gustavo
    Montes, Ciro Garcia
    de Souza Almeida, Jazon Romilson
    Ribeiro Cabral, Virginia Lucia
    INTESTINAL RESEARCH, 2019, 17 (01) : 63 - 69
  • [23] Risk Factors for Thromboembolic Complications in Inflammatory Bowel Disease: The Role of Hyperhomocysteinaemia
    Bas Oldenburg
    Bas A. C. Van Tuyl
    René van der Griend
    Rob Fijnheer
    Gerard P. van Berge Henegouwen
    Digestive Diseases and Sciences, 2005, 50 : 235 - 240
  • [24] Risk factors for thromboembolic complications in inflammatory bowel disease: The role of hyperhomocysteinaemia
    Oldenburg, B
    Van Tuyl, BAC
    van der Griend, R
    Fijnheer, R
    Henegouwen, GPV
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (02) : 235 - 240
  • [25] Risk of Venous Thromboembolism With Inflammatory Bowel Disease
    Saleh, Tarek
    Matta, Fadi
    Yaekoub, Abdo Y.
    Danescu, Septimiu
    Stein, Paul D.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2011, 17 (03) : 254 - 258
  • [26] Inflammatory bowel disease and thromboembolic events: a c'lot to learn
    Carvalho, Ana Catarina
    Pinho, Juliana
    Cancela, Eugenia
    Vieira, Hugo Marcelo
    Silva, Americo
    Ministro, Paula
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [27] Venous Thromboembolism in Patients with Inflammatory Bowel Disease
    Dhaliwal, Galvin
    Patrone, Michael V.
    Bickston, Stephen J.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [28] Risk of cardiovascular disease in inflammatory bowel disease
    Wu, Ping
    Jia, Fangyuan
    Zhang, Bao
    Zhang, Peiying
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (02) : 395 - 400
  • [29] The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease
    King, Dominic
    Chandan, Joht Singh
    Thomas, Tom
    Nirantharakumar, Krishnarajah
    Reulen, Raoul C.
    Adderley, Nicola J.
    Trudgill, Nigel
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (11) : 1731 - 1739
  • [30] Colorectal cancer risk in patients with inflammatory bowel disease
    Keller, R
    Fischbach, W
    LEBER MAGEN DARM, 2000, 30 (01) : 14 - 20